A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by National Cancer Center, Korea.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
National Cancer Center, Korea
Collaborator:
Jeil Pharmaceutical Co., Ltd.
Information provided by:
National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT00874328
First received: December 24, 2008
Last updated: October 22, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |